Study Coordinators Prefer Paper COA
A recent survey by Worldwide Clinical Trials showed coordinators' are concerned eCOA interferes with normal patient rapport.
Worldwide Clinical Trials evaluated the experiences of 1,500 clinical study coordinators who use electronic clinical outcome assessment (eCOA) technologies in a global survey and found that 67% of respondents prefer paper-based assessments over eCOA solutions, with many citing concerns that these electronic solutions may interfere with the normal patient rapport that is required during the clinical assessment process. The findings highlight important considerations for the industry, with the need for easier interfaces, simplified set-up processes, and comprehensive training – all vital in improving the usability and prevalence of these technologies.
Worldwide Clinical Trials executives believe that the transition to EDC technologies, across the board, take time but understanding the users' view is important.
Read the full release.
Merck Stops HYPERION Trial for Winrevair in PAH Following Positive ZENITH Trial Results
January 30th 2025The Phase III HYPERION trial was stopped early after strong positive interim results from the ZENITH trial demonstrated the efficacy of Winrevair (sotatercept-csrk) in treating pulmonary arterial hypertension, making it unethical to continue.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
